Structure via PubChem · Public domain (PubChem)
docetaxel
Sign in to saveAlso known as Docecad®, EmDOC, Taxotere®, TXL, N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel, N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol, docetaxel, anhydrous
Docetaxel (DTX or DXL), sold under the brand name Taxotere among others, is a chemotherapy medication used to treat a number of types of cancer. This includes breast cancer, head and neck cancer, stomach cancer, prostate cancer and non-small-cell lung cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.
Chemical data
- Formula
- C43H53NO14
- Molecular weight
- 807.9 g/mol
- IUPAC name
- [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1,9,12-trihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
- SMILES
- CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O
- InChIKey
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N
- XLogP
- 1.6
- Polar surface area
- 224 Ų
- H-bond donors
- 5
- H-bond acceptors
- 14
- Formal charge
- 0
via PubChem
Research
22,864 papers- Docetaxel.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1995
- Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy.Theranostics · 2022
- Docetaxel as a Model Compound to Promote HDL (High-Density Lipoprotein) Biogenesis and Reduce Atherosclerosis.Arteriosclerosis, thrombosis, and vascular biology · 2023
- Docetaxel-induced Flagellate Erythema - Case Report and Brief Review.Current drug safety · 2023
- The interactions of docetaxel with tumor microenvironment.International immunopharmacology · 2023
via PubMed
Wikidata facts
- Mass
- 807.347
Show 5 more facts
- chemical formula
- C₄₃H₅₃NO₁₄
- isomeric SMILES
- CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O
- canonical SMILES
- CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O
- Commons category
- Docetaxel
- stylized name
- DOCEtaxel
Sources (7)
via Wikidata · CC0
~27 min read
Article
22 sectionsContents
- Medical uses
- Outcomes
- Breast cancer
- Monitoring and combination use
- Side effects
- Contraindications and patient factors
- Pregnancy
- Drug interactions
- Chemistry
- Formulations and compositions
- Active regions
- Pharmacokinetics
- Absorption and distribution
- Metabolism and excretion
- Mechanism of action
- Molecular target
- Modes of action
- Cellular responses
- Society and culture
- Discovery, regulation and marketing
- Costs
- References
{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 461754129 | image = Docetaxel.svg | image_class = skin-invert-image | width = 250 | alt = | image2 = Docetaxel-from-xtal-3D-sk.png | image_class2 = bg-transparent | width2 = 250 | alt2 =
| tradename = Taxotere, Docecad, Docefrez, others | Drugs.com = | MedlinePlus = a696031 | DailyMedID = Docetaxel | pregnancy_AU = D | pregnancy_AU_comment = | routes_of_administration = Intravenous | ATC_prefix = L01 | ATC_suffix = CD02